Arcturus Therapeutics Holdings Inc. (ARCT) hosted its Q4 and fiscal year 2025 earnings conference call on March 3, 2026, at 4:30 p.m. ET. The session focused on financial updates and pipeline advancements for the mRNA therapeutics company.
Executive Participants
- Joseph Payne, Founder, President, CEO, and Director
- Neda Safarzadeh, Vice President and Head of Investor Relations, Public Relations, and Marketing
- Dr. Alan Cohen, Chief Medical Officer
- Dr. Pad Shibkula, Chief Scientific Officer and Chief Operating Officer
Analysts Present
- Yasmeen Rahimi, Piper Sandler & Co., Research Division
- Pete Stavropoulos, Cantor Fitzgerald & Co., Research Division
- Seamus Fernandez, Guggenheim Securities, LLC, Research Division
- Lili Nsongo, Leerink Partners LLC, Research Division
- Yanan Zhu, Wells Fargo Securities, LLC, Research Division
- Myles Minter, William Blair & Company L.L.C., Research Division
- Adam Walsh, ROTH Capital Partners, LLC, Research Division
- Angela Qian, Canaccord Genuity Corp., Research Division
- Joohwan Kim Thomas Shrader, BTIG, LLC, Research Division
- Yale Jen, Laidlaw & Company (UK) Ltd., Research Division
Call Overview
The conference opened with operator instructions for participants. Callers received notice that the session was being recorded.
Neda Safarzadeh greeted attendees and introduced the agenda. “Good afternoon, and welcome to Arcturus Therapeutics Quarterly Financial Update and Pipeline Progress Call,” she announced.
Joseph Payne, President and CEO, and Dr. Alan Cohen, Chief Medical Officer, led the main presentation. Dr. Pad Shibkula joined for the question-and-answer segment.
Forward-Looking Disclaimer
Safarzadeh highlighted that non-historical statements qualify as forward-looking under the Private Securities Litigation Reform Act of 1995. Such projections carry risks, uncertainties, and assumptions that may result in outcomes differing materially from expectations.
Investors monitoring ARCT stock can expect detailed financials and pipeline insights from this key earnings event.
